ABIN967154
antibody from antibodies-online
Targeting: MAPT
DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967154 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Microtubule-Associated Protein tau (MAPT) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized non-phosphopeptide derived from human Tau around the phosphorylation site of threonine 231 (V-R-TP-P-P).
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100 μg
- Concentration
- 100ug/100ul.
- Storage
- -20°C
Submitted references Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.
1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Characterization of in vitro glycation sites of tau.
Babu JR, Geetha T, Wooten MW
Journal of neurochemistry 2005 Jul;94(1):192-203
Journal of neurochemistry 2005 Jul;94(1):192-203
1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.
Wintjens R, Wieruszeski JM, Drobecq H, Rousselot-Pailley P, Buée L, Lippens G, Landrieu I
The Journal of biological chemistry 2001 Jul 6;276(27):25150-6
The Journal of biological chemistry 2001 Jul 6;276(27):25150-6
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Goedert M, Spillantini MG
Biochimica et biophysica acta 2000 Jul 26;1502(1):110-21
Biochimica et biophysica acta 2000 Jul 26;1502(1):110-21
Characterization of in vitro glycation sites of tau.
Nacharaju P, Ko L, Yen SH
Journal of neurochemistry 1997 Oct;69(4):1709-19
Journal of neurochemistry 1997 Oct;69(4):1709-19
No comments: Submit comment
No validations: Submit validation data